Pharmafile Logo
Pharmafocus logo
Advanced Search

China

Showing 15 posts of 255 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …

News

China urges firms to make generic versions of 34 drugs

June 25, 2019
Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …

News
inside_aryogen

Three workers killed by explosion at pharma factory in India

June 11, 2019
Manufacturing and Production China, India, explosion, manufacturing, pharma

Three engineers have been killed in an explosion at a manufacturing facility in India. Two Chinese engineers and one Indian …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA, GSK, Novartis, Pfizer, environment, opioids, pharma, pricing

The pharmaceutical industry is a big polluter than the automotive industry. This was our top story this week. The findings …

News
190131111631-01-shingles-vaccine-gsk-super-tease

China approves GSK’s shingles vaccine Shingrix

May 24, 2019
Medical Communications, Sales and Marketing China, GSK, Shingrix, pharma, shingles

GSK’s shingles vaccine has secured approval in China, the company said, after the National Medical Products Administration (NMPA) authorised the …

News
sandoz

Sandoz is first multinational to secure generic approval under new Chinese guidelines

May 20, 2019
Sales and Marketing China, Novartis, Sandoz, generics, pharma, rosuvastatin

Sandoz has revealed that its generic statin rosuvastatin, known in its branded incarnation as Crestor, has been given approval in …

News
chinese_flag_beijing_-_img_1104

Chinese pharmaceuticals will not be subject to tariffs, US Trade Representative says

May 14, 2019
Manufacturing and Production China, US, USTR, pharma, tariffs, trade

The Office of the United States Trade Representative (USTR) has said pharmaceuticals will not be subject to potential US tariffs …

News
chinese_flag_beijing_-_img_1104

China introduces new laws to ensure steady supply of drugs

April 17, 2019
Research and Development China, National Health Commission, laws, markets, pharma, regulation

China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure …

News
novartis_outside_1

Novartis’ Cosentyx approved in China for plaque psoriasis

April 2, 2019
Manufacturing and Production, Sales and Marketing China, Cosentyx, Novartis, pharma, psoriasis

Novartis has revealed that its interleukin-17A (IL-17A) Cosentyx (secukinumab) has been authorised for use in China in the treatment of …

News
merckwindow_web

China approves Keytruda for non-small cell lung cancer

April 2, 2019
Manufacturing and Production China, MSD, Merck and Co, USA, keytruda, lung cancer, pharma

US firm MSD has won approval for Keytruda in China. The cancer immunotherapy has thus become the first PD-1 inhibitor …

News
nguegvfjxvm8p1pck4yc38kuipa5nnez

Venezuela relaunch pharmaceutical industry with Chinese and Russian backing

March 21, 2019
Manufacturing and Production China, Maduro, Russia, USA, Venezuela, pharma

President Maduro has pledged to relaunch Venezuela’s pharmaceutical industry, as part of an effort to address shortages of medicines in …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

March 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, GP, Michael Cohen, Novartis, Roche, Sanofi, Senate, UK, crispr, top 10

As the CRISPR twins’ story unfolds, scientists revealed that the Chinese babies were likely altered in a way that improves …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 22, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, China, MedImmune, Xeljanz, asthma, diabetes, keytruda, osteoarthritis, pharma, rare disease

Happy Friday! With the weekend within reach, check out our run-down of the top ten most popular articles on Pharmafile.com …

News
chinese_flag_beijing_-_img_1104

China to establish national rare disease network

February 19, 2019
Manufacturing and Production China, NHC, healthcare, rare diseases

China is set to establish a national collaborative network of hospitals for rare disease diagnosis and treatment to promote early …

News
amgen_flag

China’s NMPA approves Amgen’s Repatha to reduce cardiovascular event risk

January 25, 2019
Medical Communications, Sales and Marketing Amgen, China, Repatha, cardiovascular disease, pharma, stroke

Amgen has announced that its proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor Repatha (evolocumab) has secured approval by China’s drug …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024